About Latona Life Sciences
Latona Life Sciences, Inc. is a privately-held specialty pharmaceutical company dedicated to the development and commercialization of pharmaceuticals in key therapeutic orphan drug markets.
The company has acquired the rights to the first oral human immunoglobulin, Oralgam™. This product shows potential to serve the Juvenile Idiopathic Arthritis market as well as other immune-mediated diseases.
Latona has differentiated itself by acquiring phase II/III orphan drug products and obtaining grant money to fund the clinical development of these products.
Oralgam is a registered trademark of Latona Life Sciences, Inc.